Metabolic reprogramming in childhood acute lymphoblastic leukemia
- 15 April 2020
- journal article
- review article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 67 (6) , e28255
Abstract
The first observations of altered metabolism in malignant cells were made nearly 100 years ago and therapeutic strategies targeting cell metabolism have been in clinical use for several decades. In this review, we summarize our current understanding of cell metabolism dysregulation in childhood acute lymphoblastic leukemia (cALL). Reprogramming of cellular bioenergetic processes can be expected in the three distinct stages of cALL: at diagnosis, during standard chemotherapy, and in cases of relapse. Upregulation of glycolysis, dependency on anaplerotic energy sources, and activation of the electron transport chain have all been observed in cALL. While the current treatment strategies are tackling some of these aberrations, cALL cells are likely to be able to rewire their metabolism in order to escape therapy, which may contribute to a refractory disease and relapse. Finally, here we focus on novel therapeutic approaches emerging from our evolving understanding of the alterations of different metabolic networks in lymphoblasts.Keywords
Funding Information
- Bulgarian National Science Fund (КP‐06‐H23/12)
This publication has 97 references indexed in Scilit:
- Glucose starvation induces cell death in K-ras-transformed cells by interfering with the hexosamine biosynthesis pathway and activating the unfolded protein responseCell Death & Disease, 2013
- Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose MetabolismCell, 2012
- A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALLHuman Molecular Genetics, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- A genome-wide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivityLeukemia, 2010
- Glucocorticoid use in acute lymphoblastic leukaemiaThe Lancet Oncology, 2010
- Germline genomic variants associated with childhood acute lymphoblastic leukemiaNature Genetics, 2009
- Dynamic regulation of mitochondrial function by glucocorticoidsProceedings of the National Academy of Sciences, 2009
- γ-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemiaNature Medicine, 2008
- On the Origin of Cancer CellsScience, 1956